【参考文献】

1Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema pathophysiology creening and novel therapies. Diabetes Care ,2003;26:2653-2664

2安藤伸朗著.项燕译.糖尿病黄斑水肿的治疗.日本医学介绍,1996;17:87-88

3 Malik RA, Li C, Aziz W. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med ,2005;9:692-697

4 Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol ,2004;137:313-322

5 Gottfredsdottir MS, Stefansson E，Jonasson F. Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol ,1993;115:64-67

6张伟,李君,郭秀荣,孙秀梅,魏自敏,王莉,黄显丰,胡爱平.激光光凝联合中药治疗糖尿病黄斑水肿的临床研究.国际眼科杂志,2006;6(4):913-914

7刘琼,宋燕萍,金忠秋.氪黄激光治疗糖尿病性黄斑水肿的疗效观察.中国激光医学杂志,2003;12:240-242

8王兰惠,魏景文,陈松.氪离子黄光与红光联合治疗视网膜血管病致黄斑水肿.中国实用眼科杂志,2003;21: 28-30

9 Jonas JB, Kreissig I，Sofker A. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol ,2003;121:57-61

10 Tewari HK, Sony P，Chawla R. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. Eur J Ophthalmol ,2005;15:619-626

11 Spandau UH, Derse M，Schmitz-Valckenberg P. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. Br J Ophthalmol ,2005;89:999-1003

12 Krepler K, Wagner J，Sacu S. The effect of intravitreal triamcinolone on diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol ,2005;243:478-481

13 Jonas JB, Akkoyun I，Kreissig I. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study. Br J Ophthalmol ,2005;89:321-326

14 Bonini-Filho MA, Jorge R，Barbosa JC. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci ,2005;46:3845-3849

15 Reichle ML. Complications of intravitreal steroid injections. Optometry ,2005;76:450-460

16 Zhang W, Yamamto K, Hori S. Visual outcome and complications of vitrectomy for Diabetic Macular Edena at one-year follow-up. Int J Ophthalmol (Guoji Yanke Zazhi) ,2005;5(6):1097-1103

17 Ozdemir H, Karacorlu M，Karacorlu S. Serous macular detachment in diabetic cystoid macular oedema. Acta Ophthalmol Scand ,2005;83:63-66

18 Stefaniotou M，Aspiotis M，Kalogeropoulos C.Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol ,2004;14:137-143

19 Shimura M, Saito T，Yasuda K. Clinical course of macular edema in two cases of interferon-associated retinopathy observed by optical coherence tomography. Jpn J Ophthalmol ,2005;49:231-234

20 Lang GE. Therapy of diabetic retinopathy with somatostatin analogues. Ophthalmologe , 2004;101:290-293

21 Campochiaro PA, C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci ,2004;45:922-931

22 Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol ,2004;137:675-682

23于强,鲁桂兰,赫元涛.影响糖尿病视网膜病变患者生存质量主要因素的研究.中华眼底病杂志,2000;16(3):141-143

24邵帅,于清海.增殖性糖尿病视网膜病变患者围手术期护理.吉林医学,2003;4:375-376

上一页  [1] [2] [3]